- Home
- IMMX vs NMS Comparison
IMMX vs NMS Comparison
Compare IMMX & NMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMX
- NMS
- Stock Information
- Founded
- IMMX 2014
- NMS 1993
- Country
- IMMX United States
- NMS United States
- Employees
- IMMX N/A
- NMS N/A
- Industry
- IMMX Medicinal Chemicals and Botanical Products
- NMS Finance Companies
- Sector
- IMMX Health Care
- NMS Finance
- Exchange
- IMMX Nasdaq
- NMS Nasdaq
- Market Cap
- IMMX 61.1M
- NMS 66.4M
- IPO Year
- IMMX 2021
- NMS N/A
- Fundamental
- Price
- IMMX $2.65
- NMS $11.37
- Analyst Decision
- IMMX Strong Buy
- NMS
- Analyst Count
- IMMX 1
- NMS 0
- Target Price
- IMMX $7.00
- NMS N/A
- AVG Volume (30 Days)
- IMMX 137.1K
- NMS 12.0K
- Earning Date
- IMMX 08-11-2025
- NMS 01-01-0001
- Dividend Yield
- IMMX N/A
- NMS 4.11%
- EPS Growth
- IMMX N/A
- NMS N/A
- EPS
- IMMX N/A
- NMS N/A
- Revenue
- IMMX N/A
- NMS N/A
- Revenue This Year
- IMMX N/A
- NMS N/A
- Revenue Next Year
- IMMX N/A
- NMS N/A
- P/E Ratio
- IMMX N/A
- NMS N/A
- Revenue Growth
- IMMX N/A
- NMS N/A
- 52 Week Low
- IMMX $1.26
- NMS $9.21
- 52 Week High
- IMMX $3.00
- NMS $12.18
- Technical
- Relative Strength Index (RSI)
- IMMX 61.44
- NMS 44.41
- Support Level
- IMMX $2.16
- NMS $11.30
- Resistance Level
- IMMX $2.80
- NMS $11.45
- Average True Range (ATR)
- IMMX 0.17
- NMS 0.08
- MACD
- IMMX 0.04
- NMS 0.01
- Stochastic Oscillator
- IMMX 80.00
- NMS 55.56
About IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.
About NMS Nuveen Minnesota Quality Municipal Income Fund
Nuveen Minnesota Quality Municipal Income Fund is a diversified closed-end management investment company. The Fund's primary investment objective is current income exempt from both regular federal income taxes and Minnesota state income taxes and its secondary investment objective is the enhancement of portfolio value.